Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04131868
Other study ID # K01MH103511
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 19, 2018
Est. completion date July 7, 2019

Study information

Verified date November 2019
Source University of Oregon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates whether increasing sleep duration can increase neural and behavioral response to rewards and decrease depressive symptoms in 18- to 22-year-old women with insufficient sleep and depressive symptoms.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date July 7, 2019
Est. primary completion date April 25, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 22 Years
Eligibility Inclusion Criteria:

- Insufficient sleep (total sleep time < 8 hours per night, with sleepiness scores = 6 on the Epworth Sleepiness Scale OR = 16 on the PROMIS Sleep Related Impairment Scale)

- Symptoms of depression (= 15 on the Center for Epidemiological Studies for Depression Scale)

Exclusion Criteria:

- Current insomnia, hypersomnia, sleep disordered breathing, sleep movement disorder, or circadian rhythm disorder

- History of head injury with loss of consciousness within the past two years

- History of head injury with loss of consciousness two or more years ago and meet criteria for post concussion syndrome

- Neurological disorder

- Use of psychiatric medications

- Current psychotic symptoms

- Active suicidal ideation

- Conditions that are contraindicated for MRI (e.g., ferromagnetic material in the body)

- Meet criteria for current substance use disorder with greater than mild severity

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Typical sleep opportunity
Typical sleep opportunity with consistent sleep timing for 1 week
Extended sleep opportunity
Extended sleep opportunity by 90 min per night with consistent sleep timing for 1 week

Locations

Country Name City State
United States University of Oregon Eugene Oregon

Sponsors (1)

Lead Sponsor Collaborator
University of Oregon

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depressive symptoms Center for Epidemiological Studies Depression Scale score. The CESD-R is a 20-item measure of the frequency of depressive symptoms, with each item rated on a scale from 0 (not at all or less than one day) to 5 (nearly every day). Total scores range from 0 to 100, with higher scores indicating greater number and frequency of depressive symptoms. 1 week
Primary Reward-related brain function BOLD fMRI response during Reward Guessing Task 1 week
Primary Sleep duration Mean actigraphy-measured sleep duration 1 week
Secondary Positive affect International Positive and Negative Affect Scale Short Form - Positive Affect score. The I-PANAS-SF is a 10-item scale that asks participants to rate the extent to which 5 positive and 5 negative adjectives describe them on a scale of 1 (never) to 5 (always). Scores for each positive adjective are summed to produce a Positive Affect (PA) score ranging from 5 to 25, with higher scores indicating more positive affect. 1 week
Secondary Negative affect International Positive and Negative Affect Scale Short Form - Negative Affect score. The I-PANAS-SF is a 10-item scale that asks participants to rate the extent to which 5 positive and 5 negative adjectives describe them on a scale of 1 (never) to 5 (always). Scores for each negative adjective are summed to produce a Negative Affect (PA) score ranging from 5 to 25, with higher scores indicating more negative affect. 1 week
Secondary Reward effort Effort Expenditure for Rewards Task score 1 week
Secondary Reward-related functional connectivity BOLD fMRI psychophysiological striatal-medial prefrontal cortex interaction 1 week
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A